a
<We_can_help/>

What are you looking for?

Image Alt

Program

A Welcome Message From
Our 2024 Chairman

On behalf of The Antibody Series, it is my pleasure to extend a warm invitation to you for our upcoming conference taking place in the picturesque Maderia Island from September 4th to 6th, 2024, in-person (invitational) and virtual.

We encourage you to join us for an enriching scientific experience, fostering connections with peers across industry and academia who share a passion for advancing the field of antibody discovery and development.

For The Antibody Series Community online, I’m pleased to announce that on-demand will be made free to watch post-conference. To register for on-demand access, please visit the “get involved” section. We look forward to you joining us.

 

– Dr. Paul Parren, The Antibody Series 2024 Chairman

In-person

Scientific Agenda

Wednesday Thursday Friday
09:00
George Georgiou
Understanding the Human Serological Antibody Repertoire
09:00
09:50
Christoph Rader
Creating and targeting synthetic neoepitopes on cancer cells
09:05
09:35

Marc Robillard
Click-to-Release: on-target activation and off-target deactivation of antibody-based therapies
09:35
10:05
10:00
Rob de Jong
Single molecule studies and applications of antibodies engineered to induce cell surface-restricted hexamerization
10:45
11:15

Matthew Romei
Antibody Architectures and Interfaces: Nature’s Guide to Biotherapeutic Engineering
11:15
11:45
11:00
Sally Ward
Targeting FcRn for the therapy of autoimmune disease
11:00
11:30

Mitchell Ho
Engineering Immunotoxins and CAR-T Cells for Cancer Therapy Using Nanobodies
11:30
12:00
12:00
Jannick Bendtsen
An integrated bioinformatics platform for antibody discovery: Advancing data-driven decision making for therapeutic candidate selection
12:00
12:15

Speaker TBA
12:15
12:30
Joy Zuchero
The Transport Vehicle: Engineering the Fc and Utilizing the Brain Vasculature to Deliver CNS Therapeutics
12:00
12:30
13:00
14:00
Dennis Burton
How antibodies protect against viruses
14:20
14:50

Laura Walker
mRNA-based delivery of engineered antibodies to combat SARS-CoV-2
14:50
15:20
15:00
16:00
Charlotte Deane
Moving the dial on computational antibody design
16:10
16:40

Jeffrey Gray
Artificial Intelligence Tools for Antibody Engineering
16:40
17:10

Alex Lugovskoy
Computational epitope filtering of antibody repertoires enables reliable design of agonist antibodies to multimeric receptor complexes
17:10
17:40
17:00
Andrew Ward
Deconstructing polyclonal antibody responses at the molecular level using cryoEM
17:15
18:05

Thom Sharp
Structural biology of complement initiation by the C1 complex
18:15
18:45
18:00

Wednesday

Thursday

Friday

Wednesday Thursday Friday
17:00
Andrew Ward
Deconstructing polyclonal antibody responses at the molecular level using cryoEM
17:15
18:05

Thom Sharp
Structural biology of complement initiation by the C1 complex
18:15
18:45
18:00

Wednesday

Wednesday Thursday Friday
09:00
George Georgiou
Understanding the Human Serological Antibody Repertoire
09:00
09:50
10:00
Rob de Jong
Single molecule studies and applications of antibodies engineered to induce cell surface-restricted hexamerization
10:45
11:15

Matthew Romei
Antibody Architectures and Interfaces: Nature’s Guide to Biotherapeutic Engineering
11:15
11:45
11:00

Thursday

Wednesday Thursday Friday
16:00
Charlotte Deane
Moving the dial on computational antibody design
16:10
16:40

Jeffrey Gray
Artificial Intelligence Tools for Antibody Engineering
16:40
17:10

Alex Lugovskoy
Computational epitope filtering of antibody repertoires enables reliable design of agonist antibodies to multimeric receptor complexes
17:10
17:40
17:00

Thursday

Wednesday Thursday Friday
09:00
George Georgiou
Understanding the Human Serological Antibody Repertoire
09:00
09:50
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
Andrew Ward
Deconstructing polyclonal antibody responses at the molecular level using cryoEM
17:15
18:05
18:00

Wednesday

Thursday

Wednesday Thursday Friday
09:00
Christoph Rader
Creating and targeting synthetic neoepitopes on cancer cells
09:05
09:35

Marc Robillard
Click-to-Release: on-target activation and off-target deactivation of antibody-based therapies
09:35
10:05
10:00
11:00
Sally Ward
Targeting FcRn for the therapy of autoimmune disease
11:00
11:30

Mitchell Ho
Engineering Immunotoxins and CAR-T Cells for Cancer Therapy Using Nanobodies
11:30
12:00
12:00
Joy Zuchero
The Transport Vehicle: Engineering the Fc and Utilizing the Brain Vasculature to Deliver CNS Therapeutics
12:00
12:30

Friday

Wednesday Thursday Friday
14:00
Dennis Burton
How antibodies protect against viruses
14:20
14:50

Laura Walker
mRNA-based delivery of engineered antibodies to combat SARS-CoV-2
14:50
15:20
15:00

Thursday

Wednesday Thursday Friday
12:00
Jannick Bendtsen
An integrated bioinformatics platform for antibody discovery: Advancing data-driven decision making for therapeutic candidate selection
12:00
12:15

Speaker TBA
12:15
12:30

Thursday

No events available!
The Antibody Series
Register now for free upcoming on-demand access to talks